Feofanov A, Charonov S, Fleury F, Kudelina I, Jardillier J C, Nabiev I
Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Anticancer Res. 1999 Nov-Dec;19(6B):5341-8.
It is suggested that the cytotoxicity of anticancer agent mitoxantrone (MITOX) is related to a complex combination of molecular interactions which lead to slowing of S phase traverse and arresting of cells in G2 phase of the cell cycle or even to an apoptosis at high concentration of MITOX. Here intracellular molecular interactions of MITOX were visualised and studied using the confocal spectral imaging technique in synchronised K562 cells. Localisation, quantitative distributions of MITOX in the polar environment, MITOX bound to hydrophobic cellular structures (MITOXphob), nucleic acid-related complexes of MITOX (MITOXNA) and relative distributions of naphthoquinoxaline (NQX) metabolite and intrinsic cellular fluorescence of porphyrins were measured within cytoplasmic and nuclear compartments (chromosomes) of the G2, S, and M cells treated with 10 or 2 microM of MITOX for 1 hour. Colocalisation of MITOX, NQX metabolite and sites of intrinsic cellular fluorescence indicates an accumulation of MITOX within or near mitochondria. One may suppose that due to high concentration MITOX can compete with natural substrates for binding to the enzymes thus affecting the normal functioning of a mitochondria. A remarkable redistribution of MITOX and its complexes occurs in the M cells. In particular, a prominent amount of MITOX is associated with the surface of chromatids but not with the cytoplasmic structures in M cells. At the present time the exact location of the sites of MITOX accumulation in the M cells is not known. It is thought to be some cytoskeleton/microtubule structures associated directly with the chromosomes. Selective labelling of particular cytoskeleton structures and/or proteins in MITOX treated cells is in the progress now and the question will be addressed using the CSI technique.
有人提出,抗癌药物米托蒽醌(MITOX)的细胞毒性与一系列复杂的分子相互作用有关,这些相互作用会导致S期进程减慢,细胞在细胞周期的G2期停滞,甚至在高浓度MITOX作用下引发细胞凋亡。在此,利用共聚焦光谱成像技术,对同步化的K562细胞中MITOX的细胞内分子相互作用进行了可视化和研究。测量了用10或2微摩尔/升的MITOX处理1小时的G2、S和M期细胞的细胞质和细胞核区室(染色体)内MITOX的定位、在极性环境中的定量分布、与疏水细胞结构结合的MITOX(MITOXphob)、与核酸相关的MITOX复合物(MITOXNA)以及萘并喹喔啉(NQX)代谢物和卟啉的细胞内固有荧光的相对分布。MITOX、NQX代谢物和细胞内固有荧光位点的共定位表明MITOX在线粒体内或线粒体附近积累。可以推测,由于高浓度的MITOX,它可能会与天然底物竞争与酶的结合,从而影响线粒体的正常功能。在M期细胞中,MITOX及其复合物会发生显著的重新分布。特别是,大量的MITOX与M期细胞中染色单体的表面相关,而与细胞质结构无关。目前尚不清楚MITOX在M期细胞中积累位点的确切位置。据认为是一些与染色体直接相关的细胞骨架/微管结构。目前正在对MITOX处理的细胞中特定细胞骨架结构和/或蛋白质进行选择性标记,这个问题将使用CSI技术来解决。